lysine has been researched along with Adenocystic Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komander, D | 1 |
Canninga-van Dijk, MR; Clevers, H; Edelmann, MJ; Haegebarth, A; Henraat, M; Kessler, BM; Kuper, I; Maurice, MM; Tauriello, DV | 1 |
2 other study(ies) available for lysine and Adenocystic Carcinoma
Article | Year |
---|---|
CYLD tidies up dishevelled signaling.
Topics: Adaptor Proteins, Signal Transducing; Animals; beta Catenin; Carcinoma, Adenoid Cystic; Deubiquitinating Enzyme CYLD; Dishevelled Proteins; Humans; Lysine; Mutation; Phosphoproteins; Protein Processing, Post-Translational; Signal Transduction; Skin Neoplasms; Transcriptional Activation; Tumor Suppressor Proteins; Ubiquitination; Wnt Proteins; Wnt3 Protein | 2010 |
Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Topics: Adaptor Proteins, Signal Transducing; Animals; beta Catenin; Carcinoma, Adenoid Cystic; Carcinoma, Skin Appendage; Cell Proliferation; Deubiquitinating Enzyme CYLD; Dishevelled Proteins; HeLa Cells; Humans; Lysine; Mice; Mutation; NF-kappa B; Phosphoproteins; Protein Multimerization; Protein Processing, Post-Translational; Protein Structure, Tertiary; RNA Interference; Signal Transduction; Skin Neoplasms; Time Factors; Transcriptional Activation; Transfection; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Ubiquitination; Wnt Proteins; Wnt3 Protein | 2010 |